Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04345185 · ClinicalTrials.gov registry record
Effects of Infant Egg Consumption on Child Health and Cognition Development
A clinical trial of Obesity and Metabolic Syndrome, sponsored by State University of New York at Buffalo.
- Completed
- Registry status
- 5,374
- Enrollment target
- 1
- Study location
NCT04345185: Completed study of Obesity and Metabolic Syndrome, sponsored by State University of New York at Buffalo.
NCT04345185 is a study of Obesity and Metabolic Syndrome that has completed, run by State University of New York at Buffalo. The registered enrollment target is 5,374 participants, above the 814-participant average among 1,053 other Obesity trials with a reported enrollment target (560% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04345185, a study of Obesity and Metabolic Syndrome, has completed, sponsored by State University of New York at Buffalo.
- COMPLETED
- Registry status
- 5,374 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to examine how infant egg consumption (age of introduction and frequency of intake) influences physical growth, obesity, cardio-metabolic health, risk of food allergy, and cognition development in mid-childhood and adolescence.
Primary Outcome
Research staff measured children's weight in Project Viva.
Conditions Studied
Interventions
- OTHER Infant egg consumption (i.e., age of introduction and frequency of intake)
Study Locations (1)
New York
- Division of Behavioral Medicine Department of Pediatrics Jacobs School of Medicine and Biomedical Sciences State University of New York at Buffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,374 participants |
| Start Date | 1999-01-01 |
| Est. Completion | 2019-11-30 |
What the finished NCT04345185 record still lists
NCT04345185 is an observational study that tracks outcomes without assigning an intervention. Its 5,374 participants enrollment target places it among the larger protocols in the corpus, above the 814-participant average among 1,053 other Obesity trials with a reported enrollment target (560% higher).
The record links to 6 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Infant egg consumption (i.e., age of introduction and frequency of intake) is the first listed.
NCT04345185 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT04345185 about?
NCT04345185 is a clinical study titled "Effects of Infant Egg Consumption on Child Health and Cognition Development". The objective of this study is to examine how infant egg consumption (age of introduction and frequency of intake) influences physical growth, obesity, cardio-metabolic health, risk of food allergy, and cognition development in mid-childhood and adolescence.
What is the current status of trial NCT04345185?
This trial is currently completed. The enrollment target is 5,374 participants. The study started on 1999-01-01. Estimated completion is 2019-11-30.
What conditions does trial NCT04345185 study?
This clinical trial studies the following conditions: Obesity, Metabolic Syndrome, Cardiovascular Risk Factor, Food Allergy, Growth & Development.
What interventions are being tested in trial NCT04345185?
The interventions under investigation include: Infant egg consumption (i.e., age of introduction and frequency of intake) (OTHER).
Who is sponsoring clinical trial NCT04345185?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04345185 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04345185's enrollment target sits among peer trials
5,374 17th of 1053 higher than 1,037 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Hip Flexion Feedback System for Exercise Monitoring in Individuals With Osteoarthritis and Obesity
RECRUITING · Phase 1
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Tirzepatide: Reversal of Lipotoxicity and Adipose Tissue Dysfunction in Humans With Overweight/Obesity
RECRUITING · Phase 2
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05836987 · 5,350 participants · Phase 3
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- NCT05722769 · 5,408 participants · NA
CSTOP Now! Child Sex Trafficking Stops With You
- NCT05373771 · 5,328 participants · NA
Sickle Cell Improvement: Enhancing Care in the Emergency Department
- NCT04295486 · 5,478 participants · Phase 2
Optimal Dosing For Low-Dose Aspirin Chemoprophylaxis For VTE Following Total Joint Arthroplasty
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI